drugset / Trial / NCT00307593
RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
RandomizedFactorialOpen-labelTreatment
Summary
The purpose of this study is to compare a 2 immunosuppressant regimen for the treatment of relapsing or refractory necrotizing antineutrophil cytoplasmic antibody (ANCA) associated vasculitides.
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Infliximab | Monoclonal antibody | — | — |
| Comparator | Rituximab | Monoclonal antibody | — | — |